Daniel Gerlich

Last updated

Daniel Wolfram Gerlich (born 1972 in Frankfurt am Main, Germany) is a German cell biologist. Since 2012 he has been a Senior Group Leader [1] at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.

Contents

Education and career

Daniel Gerlich [2] studied biology at the University of Freiburg in Germany. Following his graduation in 1998, he worked at German Cancer Research Center (DKFZ) and Ruprecht-Karls University Heidelberg, Germany, to obtain a PhD in 2002. That year, he started postdoctoral research in the laboratory of Jan Ellenberg at the European Molecular Biology Laboratory (EMBL) in Heidelberg. In 2005 he was appointed Assistant Professor at the Institute of Biochemistry at the Swiss Federal Institute of Technology in Zurich (ETHZ). He moved to the Institute of Molecular Biotechnology (IMBA), part of the Vienna BioCenter, in 2012 to take up a Senior Group Leader position. Since 2014 he is also an Editorial Advisory Board Member of the Journal of Cell Science and from 2015 to 2019 was a member of the “Gentechnikkommission” [3] – an advisory board of the Ministry of Health of the Austrian Government.

Research focus

Gerlich's work investigates the spatial organization and biomechanics of human chromosomes. By combining cell biology, biophysics, biochemistry, and computer science approaches, he aims to elucidate how chromosomes reorganize during cell cycle progression and how they rebuild a cell nucleus after cell division. [4] [5]

His work has been awarded multiple grants from the WWTF, the FWF and two prestigious ERC grants. [6] [7] [8] [9]

Awards and honours

Related Research Articles

Carlos Martínez Alonso, was born in Villasimpliz, in the province of León, on January 9, 1950. In 1974 he obtained a chemistry degree from the Universidad Complutense of Madrid. Four years later, in 1978, he obtained a Ph.D. in immunology by the same university. He was appointed President of the Spanish National Research Council (CSIC) from 2004 to 2008, and Secretary of State for Research in the Ministry of Science and Innovation from early 2008 to December 2009.

<span class="mw-page-title-main">Giulio Superti-Furga</span> Italian molecular and systems biologist

Giulio Superti-Furga is an Italian molecular and systems biologist based in Vienna, Austria. He is the Scientific Director of CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, and Professor of Medical Systems Biology at the Medical University of Vienna. In January 2024, he was appointed Chair of EU-LIFE, the alliance of research institutes advocating for excellent research in Europe.

<span class="mw-page-title-main">Research Institute of Molecular Pathology</span>

The Research Institute of Molecular Pathology (IMP) is a biomedical research center, which conducts curiosity-driven basic research in the molecular life sciences.

<span class="mw-page-title-main">Institute of Molecular Biotechnology</span> Austrian biomedical research organisation

The Institute of Molecular Biotechnology (IMBA) is an independent biomedical research organisation founded by the Austrian Academy of Sciences in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research. IMBA is located at the Vienna BioCenter (VBC) and shares facilities and scientific training programs with the Gregor Mendel Institute of Molecular Plant Biology (GMI) of the Austrian Academy of Sciences and the Research Institute of Molecular Pathology (IMP), the basic research center of Boehringer Ingelheim.

The Wittgenstein Award is an Austrian science award supporting the notion that "scientists should be guaranteed the greatest possible freedom and flexibility in the performance of their research." The prize money of up to 1.5 million euro make it the most highly endowed science award of Austria, money that is tied to research activities within the five years following the award. The Wittgenstein-Preis is named after the philosopher Ludwig Wittgenstein and is conferred once per year by the Austrian Science Fund on behalf of the Austrian Ministry for Science.

CellCognition is a free open-source computational framework for quantitative analysis of high-throughput fluorescence microscopy (time-lapse) images in the field of bioimage informatics and systems microscopy. The CellCognition framework uses image processing, computer vision and machine learning techniques for single-cell tracking and classification of cell morphologies. This enables measurements of temporal progression of cell phases, modeling of cellular dynamics and generation of phenotype map.

<span class="mw-page-title-main">Vienna Biocenter</span> Group of life science research institutes in Vienna, Austria

The Vienna BioCenter is a cluster of life science research institutes and biotechnology companies located in the 3rd municipal District of Vienna, Austria. It grew around the Research Institute of Molecular Pathology (IMP), which opened in 1988. The entities at the Vienna BioCenter employ more than 2,000 people, including 600 students.

Elly Margaret Tanaka is a biochemist and Scientific Director at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) in Vienna, Austria. Tanaka studies the molecular cell biology of limb and spinal cord regeneration as well as the evolution of regeneration.

<span class="mw-page-title-main">Denise P. Barlow</span> British geneticist

Denise P. Barlow was a British geneticist who worked in the field of epigenomics. Barlow was an elected member of European Molecular Biology Organization (EMBO), an honorary professor of genetics at the University of Vienna and recipient of the Erwin Schrödinger Prize of the Austrian Academy of Sciences. In 1991, she discovered the first mammalian imprinted gene, IGF2R, which codes for the insulin-like growth factor.

Jan-Michael Peters is a cell- and molecular biologist. Since 2013, he is Scientific Director of the Research Institute of Molecular Pathology (IMP) in Vienna.

Alexander Stark is a biochemist and computational biologist working on the regulation of gene expression in development. He is a senior scientist at the Research Institute of Molecular Pathology (IMP) at the Vienna Biocenter and adjunct professor of the Medical University of Vienna.

<span class="mw-page-title-main">Melina Schuh</span> German molecular biologist

Melina Schuh is a German biochemist and Director at the Max Planck Institute for Multidisciplinary Sciences. She is known for her work on meiosis in mammalian oocytes, for her studies on the mechanisms leading to the age-related decline in female fertility, and for the development of the Trim-Away protein depletion method.

Meinrad Busslinger is a biochemist and immunologist, renown for his work on B cells. He is a Senior Scientist and Scientific Deputy Director of the Research Institute of Molecular Pathology (IMP) in Vienna, Austria.

<span class="mw-page-title-main">Jürgen Knoblich</span> German molecular biologist

Jürgen Knoblich is a German molecular biologist. Since 2018, he is the interim Scientific Director of the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.  

Julius Brennecke is a German molecular biologist and geneticist. He is a Senior Group Leader at the Institute of Molecular Biotechnology. (IMBA) of the Austrian Academy of Sciences in Vienna.

Kikuë Tachibana is a Japanese-Austrian molecular biologist and director at the Max Planck Institute of Biochemistry (MPIB) in Martinsried, Germany. Formerly, she was a group leader at the Institute of Molecular Biotechnology (IMBA) in Vienna, Austria.

<span class="mw-page-title-main">Dirk Schübeler</span> German molecular biology researcher (born 1969)

Dirk Schübeler is a German researcher, Director of the Friedrich Miescher Institute for Biomedical Research (FMI) and professor at the University of Basel. He is an expert in gene regulation.

<span class="mw-page-title-main">Eilika Weber-Ban</span> German biochemist

Eilika Weber-Ban is a German biochemist. Her research considers protein degradation pathways. She was elected to the European Molecular Biology Organization in 2021.

<span class="mw-page-title-main">Andrea Pauli</span> German developmental biologist and biochemist

Andrea Pauli is a developmental biologist and biochemist studying how the egg transitions into an embryo, and more specifically the molecular mechanisms underlying vertebrate fertilisations, egg dormancy, and subsequent egg activation. Her lab uses zebrafish as the main model organism. Andrea Pauli is a group leader at the Research Institute of Molecular Pathology (IMP) at the Vienna Biocenter in Austria.

<span class="mw-page-title-main">Paola Picotti</span> Italian biologist and academic

Paola Picotti is an Italian biochemist who is Professor for Molecular Systems Biology at ETH Zürich. She is Deputy Head of the Institute for Molecular Systems Biology. Her research investigates how the conformational changes of proteins impact molecular networks with cells. She received numerous awarded awards, among which the 2019 EMBO Gold Medal.

References

  1. ↑ "Daniel Gerlich". IMBA – Institute of Molecular Biotechnology. Retrieved 2019-07-16.
  2. ↑ "Daniel Gerlich | PhD | IMBA Institute Of Molecular Biotechnology, Vienna | ResearchGate". ResearchGate. Retrieved 2019-07-16.
  3. ↑ "GENTECHNIKKOMMISSION – PDF Kostenfreier Download". docplayer.org. Retrieved 2021-01-14.
  4. ↑ Mitter, Michael; Gasser, Catherina; Takacs, Zsuzsanna; Langer, Christoph C. H.; Tang, Wen; Jessberger, Gregor; Beales, Charlie T.; Neuner, Eva; Ameres, Stefan L.; Peters, Jan-Michael; Goloborodko, Anton (October 2020). "Conformation of sister chromatids in the replicated human genome". Nature. 586 (7827): 139–144. Bibcode:2020Natur.586..139M. doi:10.1038/s41586-020-2744-4. ISSN   1476-4687. PMC   7116725 . PMID   32968280.
  5. ↑ Cuylen, Sara; Blaukopf, Claudia; Politi, Antonio Z.; Müller-Reichert, Thomas; Neumann, Beate; Poser, Ina; Ellenberg, Jan; Hyman, Anthony A.; Gerlich, Daniel W. (14 July 2016). "Ki-67 acts as a biological surfactant to disperse mitotic chromosomes". Nature. 535 (7611): 308–312. Bibcode:2016Natur.535..308C. doi:10.1038/nature18610. ISSN   1476-4687. PMC   4947524 . PMID   27362226.
  6. ↑ "Life Sciences – Programmes – WWTF – Vienna Science and Technology Fund". www.wwtf.at. Retrieved 2021-01-14.
  7. ↑ Dr. Michael Strassnig. "Life Sciences – Programme – WWTF – Wiener Wissenschafts-, Forschungs- und Technologiefonds". www.wwtf.at (in German). Retrieved 2021-01-14.
  8. ↑ Dr. Michael Strassnig. "Life Sciences – Programme – WWTF – Wiener Wissenschafts-, Forschungs- und Technologiefonds". www.wwtf.at (in German). Retrieved 2021-01-14.
  9. ↑ "FWF Project Finder – Auswahlmaske". pf.fwf.ac.at. Retrieved 2021-01-14.
  10. ↑ "Daniel Gerlich : European Science Foundation". archives.esf.org. Retrieved 2021-01-14.
  11. ↑ "New recruits in fight against cancer and diabetes". www.ethlife.ethz.ch. Retrieved 2021-01-14.
  12. ↑ "ERC FUNDED PROJECTS". ERC: European Research Council. Archived from the original on 2021-01-13. Retrieved 2021-01-14.
  13. ↑ "Find people in the EMBO Communities". people.embo.org. Retrieved 2019-07-16.
  14. ↑ "ERC Advanced Grants 2021" (PDF). Archived (PDF) from the original on 2021-04-22.
  15. ↑ "Daniel Gerlich elected to Academia Europaea".{{cite web}}: CS1 maint: url-status (link)
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.